Cargando…
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
SIMPLE SUMMARY: Bruton’s Tyrosine Kinase (BTK) was originally considered to be primarily expressed in cells of hematopoietic origin. Apart from the 77 kDa BTK isoform expressed in immune cells, elevated expression of novel BTK isoforms of 80 and 65 kDa have been recently described for several solid...
Autores principales: | Betzler, Annika C., Strobel, Hannah, Abou Kors, Tsima, Ezić, Jasmin, Lesakova, Kristina, Pscheid, Ronja, Azoitei, Ninel, Sporleder, Johanna, Staufenberg, Anna-Rebekka, Drees, Robert, Weissinger, Stephanie E., Greve, Jens, Doescher, Johannes, Theodoraki, Marie-Nicole, Schuler, Patrick J., Laban, Simon, Kibe, Toshiro, Kishida, Michiko, Kishida, Shosei, Idel, Christian, Hoffmann, Thomas K., Lavitrano, Marialuisa, Grassilli, Emanuela, Brunner, Cornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818583/ https://www.ncbi.nlm.nih.gov/pubmed/36612306 http://dx.doi.org/10.3390/cancers15010310 |
Ejemplares similares
-
Influence of Bruton’s Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Leichtle, Franziska, et al.
Publicado: (2023) -
BTK, the new kid on the (oncology) block?
por: Grassilli, Emanuela, et al.
Publicado: (2022) -
Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
por: Puntigam, Lisa K., et al.
Publicado: (2020) -
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors
por: Grassilli, Emanuela, et al.
Publicado: (2021) -
Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice
por: Brand, Matthias, et al.
Publicado: (2020)